Chronic Spontaneous Urticaria After New Coronavirus Infection: Clinical Cases
Aset Kh. Ibisheva,
Madina R. Shakhgireeva,
Linda V.-M. Dzhabrailova,
Asya B. Khildikharoeva,
Linda S. Uspanova,
Kamila A.-R. Getaeva https://doi.org/10.15690/pf.v21i5.2798
Abstract
Background. Inefficacy of conventional chronic spontaneous urticaria (CSU) treatments significantly reduces patients’ quality of life. Data on CSU (triggered by new coronavirus infection) prevalence and course in children is very limited.
Clinical case description. Authors have presented three clinical cases of CSU onset after the new coronavirus infection. Clinical features of disease and targeted therapy efficacy were evaluated.
Conclusion. The course of CSU, potentially triggered by SARS-CoV-2, has its own features, and requires larger research with the study of clinical and laboratory aspects, as well as the immunological mechanisms underlying the disease, with revealing biomarkers indicating disease severity, course, and prognosis.
About the Authors
Aset Kh. Ibisheva
Republican Children’s Clinical Hospital named after E.P. Glinka
Russian Federation
Disclosure of interest:
Russian Federation
Aset Kh. Ibisheva, MD
101, Bisultanova Str., Grozny, 364028
Disclosure of interest:
Not declared
Madina R. Shakhgireeva
Republican Children’s Clinical Hospital named after E.P. Glinka
Russian Federation
Disclosure of interest:
Russian Federation
Madina R. Shakhgireeva, MD
Grozny
Disclosure of interest:
Not declared
Linda V.-M. Dzhabrailova
Republican Children’s Clinical Hospital named after E.P. Glinka
Russian Federation
Disclosure of interest:
Russian Federation
Linda V.-M. Dzhabrailova, MD
Grozny
Disclosure of interest:
Not declared
Asya B. Khildikharoeva
Republican Children’s Clinical Hospital named after E.P. Glinka
Russian Federation
Disclosure of interest:
Russian Federation
Asya B. Khildikharoeva, MD
Grozny
Disclosure of interest:
Not declared
Linda S. Uspanova
Republican Children’s Clinical Hospital named after E.P. Glinka
Russian Federation
Disclosure of interest:
Russian Federation
Linda S. Uspanova, MD
Grozny
Disclosure of interest:
Not declared
Kamila A.-R. Getaeva
Republican Children’s Clinical Hospital named after E.P. Glinka
Russian Federation
Disclosure of interest:
Russian Federation
Kamila A.-R. Getaeva, MD
Grozny
Disclosure of interest:
Not declared
References
1. Hon KL, Leung AKC, Ng WGG, Loo SK. Chronic Urticaria: An Overview of Treatment and Recent Patents. Recent Pat Inflamm Allergy Drug Discov. 2019;13(1):27–37. https://doi.org/10.2174/1872213X13666190328164931
2. Barzilai A, Baum A, Ben-Shoshan M, et al. Epidemiological and Clinical Characteristics of Adult and Pediatric Patients with Chronic Spontaneous Urticaria. J Clin Med. 2023;12(23):7482. https://doi.org/10.3390/jcm12237482
3. Revyakina VA, Kuvshinova ED, Larkova IA, et al. Chronic urticaria in a 2.5 year old child: the first domestic experience of using omalizumab. Pediatria. Journal n.a. G.N. Speransky. 2016;95(5):158–161. (In Russ).
4. Shatalova OV, Ponomareva AV, Razvalyaeva OV. Vozmozhnye prediktory effektivnosti terapii Omalizumabom tyazheloi khronicheskoi spontannoi krapivnitsy. Lekarstvennyi vestnik. 2021;15(4):48–52. (In Russ).
5. Akca HM, Tuncer Kara K. Evaluation of urticaria patients before and during the period of the COVID-19 pandemic: A retrospective study. Dermatol Ther. 2021;34(2):e14800. https://doi.org/10.1111/dth.14800
6. Крапивница: клинические рекомендации. — Минздрав России; 2023. [Krapivnitsa: Clinical guidelines. Ministry of Health of Russian Federation; 2023. (In Russ).] Доступно по: https://cr.minzdrav.gov.ru/recomend/25_2. Ссылка активна на 26.06.2024.
7. Kolkhir P, Metz M, Altrichter S, et al. Comorbidity of chronic spontaneous urticaria and autoimmune thyroid diseases: A systematic review. Allergy. 2017;72(10):1440–1460. https://doi.org/10.1111/all.13182
8. Ghazanfar MN, Thomsen SF. D-dimer as a potential blood biomarker for disease activity and treatment response in chronic urticaria: a focused review. Eur J Dermatol. 2018;28(6):731–735. https://doi.org/10.1684/ejd.2018.3443
9. Licari A, Manti S, Leonardi S, et al. Biologic drugs in chronic spontaneous urticaria. Acta Biomed. 2021;92(S7):e2021527. https://doi.org/10.23750/abm.v92iS7.12415
10. Mustari AP, Bishnoi A, Kumaran MS. Biologicals in Treatment of Chronic Urticaria: A Narrative Review. Indian Dermatol Online J. 2022;14(1):9–20. https://doi.org/10.4103/idoj.idoj_145_22
11. Manti S, Giallongo A, Papale M, et al. Monoclonal Antibodies in Treating Chronic Spontaneous Urticaria: New Drugs for an Old Disease. J Clin Med. 2022;11(15):4453. https://doi.org/10.3390/jcm11154453
Review
For citations:
Ibisheva A.Kh., Shakhgireeva M.R., Dzhabrailova L.V., Khildikharoeva A.B., Uspanova L.S., Getaeva K.A. Chronic Spontaneous Urticaria After New Coronavirus Infection: Clinical Cases. Pediatric pharmacology. 2024;21(6):496-502. (In Russ.) https://doi.org/10.15690/pf.v21i5.2798
Views:
373
Email this article 